XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Operating Segments (Tables)
6 Months Ended
Jun. 30, 2023
Operating Segments  
Schedule of operating segments

    

Three Months Ended

    

June 30, 

    

2023

    

2022

Revenues

  

 

  

Specialized BioTherapeutics

$

68,505

$

Public Health Solutions

138,424

228,640

Total

$

206,929

$

228,640

Income (loss) from Operations

 

  

 

  

Specialized BioTherapeutics

$

(611,300)

$

(2,000,350)

Public Health Solutions

(2,247)

(1,002)

Corporate

 

(1,016,777)

 

(1,393,944)

Total

$

(1,630,324)

$

(3,395,296)

Amortization and Depreciation Expense

 

  

 

  

Specialized BioTherapeutics

$

954

$

2,783

Public Health Solutions

159

463

Corporate

 

477

 

5,266

Total

$

1,590

$

8,512

Other (Expense) Income, Net

 

  

 

  

Specialized BioTherapeutics

$

9,931

$

68,509

Corporate

 

8,369

 

(214,908)

Total

$

18,300

$

(146,399)

Share-Based Compensation

 

  

 

  

Specialized BioTherapeutics

$

27,427

$

28,343

Public Health Solutions

994

1,054

Corporate

 

61,621

 

42,273

Total

$

90,042

$

71,670

    

Six Months Ended

    

June 30, 

    

2023

    

2022

Revenues

  

 

  

Specialized BioTherapeutics

$

223,870

$

Public Health Solutions

240,237

416,703

Total

$

464,107

$

416,703

Income (loss) from Operations

 

  

 

  

Specialized BioTherapeutics

$

(1,521,677)

$

(3,540,078)

Public Health Solutions

(1,820)

(121,623)

Corporate

 

(2,257,516)

 

(3,925,981)

Total

$

(3,781,013)

$

(7,587,682)

Amortization and Depreciation Expense

 

  

 

  

Specialized BioTherapeutics

$

2,025

$

5,397

Public Health Solutions

337

899

Corporate

 

1,013

 

10,448

Total

$

3,375

$

16,744

Other (Expense) Income, Net

 

  

 

  

Specialized BioTherapeutics

$

16,013

$

123,588

Corporate

 

(54,330)

 

(426,622)

Total

$

(38,317)

$

(303,034)

Share-Based Compensation

 

  

 

  

Specialized BioTherapeutics

$

54,854

$

56,847

Public Health Solutions

1,988

2,108

Corporate

 

106,834

 

90,986

Total

$

163,676

$

149,941

    

As of

As of

    

June 30, 

December 31, 

    

2023

    

2022

    

Identifiable Assets

 

  

 

  

 

Specialized BioTherapeutics

$

79,830

$

103,742

Public Health Solutions

 

118,791

 

121,290

Corporate

 

13,627,632

 

14,054,685

Total

$

13,826,253

$

14,279,717